Pancreatic Enzyme Replacement Therapy: Shortages

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body

Department of Health and Social Care

Tabled

4 Oct 2024

Target answer date

8 Oct 2024

Answer

11 Oct 2024 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

• Alcoholic Drinks: Misuse · 7 Oct 2024
• Alcoholic Drinks: Misuse · 7 Oct 2024
• Migrants: Health Services and Temporary Accommodation · 9 Oct 2024
• Asylum and Migrants: Disinformation · 21 Oct 2024
• Mental Health Services: Recruitment · 21 Oct 2024

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

• Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
• Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
• Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

1. 4 Oct 2024

   Question tabled

   To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle shortages of Pancreatic Enzyme Replacement Therapy.

2. 8 Oct 2024

   Target answer date

   Date supplied by the official written-questions record.

3. 11 Oct 2024

   Answer published

   The Department has been working with suppliers to address current supply issues with Creon, which is used by patients with conditions such as cystic fibrosis and certain cancers including pancreatic cancer. The supply issues with Creon are impacting count...

Official data retrieved 27 Sept 2026.